DexCom, Inc.
DXCM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $4.66B | $4.03B | +15.6% |
| Operating income | $912M | $600M | +52.0% |
| Net income | $836M | $576M | +45.1% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $1.34B | $1.21B | +11.2% |
| Operating income | $327M | $242M | +34.9% |
| Net income | $275M | $284M | −3.1% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Dexcom's revenue in FY2025?
- $4.66B in FY2025 (Fiscal year ended Dec 31, 2025), +15.6% vs $4.03B a year earlier, per its 10-K filed Feb 2026.
- Was Dexcom profitable in FY2025?
- Yes: net income was $836M and operating income $912M in FY2025.
- What was Dexcom's revenue in Q3 2026?
- $1.34B (+11.2% vs a year earlier), per its Form 10-Q filed Oct 29, 2026.